Scott Bussom
Impact in
- Pharmacology top 2%
- Pharmacological Effects of Natural Compounds
- Flavonoids in Medical Research
-
- Traditional Chinese Medicine Analysis
Papers in
-
- Cancer, Hypoxia, and Metabolism 2
- Cancer Genomics and Diagnostics 2
- Co-authors
- Wing LamYung‐Chi ChengZaoli JiangFulan GuanShwu-Huey LiuElizabeth A. GullenWei ZhangMuhammad Wasif Saif
- Journals
- Journal of Clinical Oncology (2 papers)Molecular Cancer Therapeutics (1 paper)Scientific Reports (1 paper)Science Translational Medicine (1 paper)DNA repair (1 paper)
- Partner nations
- United StatesChinaItaly
In The Last Decade
Scott Bussom
14 papers receiving 730 citations
Peers
Comparison fields: 5 of 79
- Pharmacology 178
- Complementary and alternative medicine 136
- Pharmacology 140
- Toxicology 24
- Oncology 170
Countries citing papers authored by Scott Bussom
This map shows the geographic impact of Scott Bussom's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Scott Bussom with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Scott Bussom more than expected).
Fields of papers citing papers by Scott Bussom
This network shows the impact of papers produced by Scott Bussom. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Scott Bussom. The network helps show where Scott Bussom may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Scott Bussom, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2015 | 94 | |
| 2 | 2013 | 61 | |
| 3 | 2011 | 61 | |
| 4 | 2010 | 72 | |
| 5 | 2010 | 4 | |
| 6 | Intraductal papillary mucinous neoplasia (IPMN). Highlights from the "2010 ASCO Gastrointestinal Cancers Symposium". Orlando, FL, USA. January 22-24, 2010. | 2010 | 4 |
| 7 | 2010 | 284 | |
| 8 | 2010 | 4 | |
| 9 | Methods and rationale for the early detection of pancreatic cancer. Highlights from the "2010 ASCO Gastrointestinal Cancers Symposium". Orlando, FL, USA. January 22-24, 2010. | 2010 | 27 |
| 10 | Abstract #4584: Exploration of the mechanisms of PHY906 in reducing the intestinal toxicity caused by irinotecan | 2009 | 2 |
| 11 | 2009 | 29 | |
| 12 | 2009 | 19 | |
| 13 | 2007 | 12 | |
| 14 | 2007 | 70 |
About Scott Bussom
Scott Bussom is a scholar working on Pharmacology, Cancer Research, Toxicology, Complementary and alternative medicine and Oncology, having authored 14 papers that have together received 743 indexed citations. Recurring topics across this work include Pancreatic and Hepatic Oncology Research (4 papers), Cancer, Hypoxia, and Metabolism (2 papers), Colorectal Cancer Treatments and Studies (2 papers), Traditional Chinese Medicine Analysis (2 papers), RNA modifications and cancer (2 papers), Immune cells in cancer (2 papers), Cancer Genomics and Diagnostics (2 papers) and Cancer-related Molecular Pathways (2 papers). The work is most often cited by research in Pharmacology (178 citations), Complementary and alternative medicine (136 citations), Pharmacology (140 citations), Toxicology (24 citations) and Oncology (170 citations). Scott Bussom has collaborated with scholars based in United States, China and Italy. Frequent co-authors include Wing Lam, Yung‐Chi Cheng, Zaoli Jiang, Fulan Guan, Shwu-Huey Liu, Elizabeth A. Gullen, Wei Zhang, Muhammad Wasif Saif, Yung-Chi Cheng and Jing Wang. Their work appears in journals such as Journal of Clinical Oncology, Molecular Cancer Therapeutics, Scientific Reports, Science Translational Medicine and DNA repair.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.